{"id":"https://openalex.org/W34455977","doi":null,"title":"Anticonvulsant drugs: mechanisms of action.","display_name":"Anticonvulsant drugs: mechanisms of action.","alternate_titles":[],"publication_year":1986,"publication_date":"1986-01-01","ids":{"openalex":"https://openalex.org/W34455977","mag":"34455977","pmid":"https://pubmed.ncbi.nlm.nih.gov/2871724"},"language":"en","primary_location":{"id":"pmid:2871724","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/2871724","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Advances in neurology","raw_type":"Journal Article"},"parent_works":[],"lineage":["https://openalex.org/W34455977"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5044198884","display_name":"Robert L. Macdonald","orcid":"https://orcid.org/0000-0002-9539-5556","observed_orcids":["https://orcid.org/0000-0002-9539-5556"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"R L Macdonald","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5104706893","display_name":"Michael J. McLean","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"M J McLean","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":9.4756,"has_fulltext":false,"cited_by_count":261,"citation_normalized_percentile":{"value":0.98527988,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":87,"max":98},"biblio":{"volume":"44","issue":null,"first_page":"713","last_page":"736"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10094","display_name":"Epilepsy research and treatment","score":0.9937000274658203,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10094","display_name":"Epilepsy research and treatment","score":0.9937000274658203,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10077","display_name":"Neuroscience and Neuropharmacology Research","score":0.004800000227987766,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10493","display_name":"Ion channel regulation and function","score":0.0005000000237487257,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/antiepileptic-drugs","display_name":"antiepileptic drugs","score":0.9620000123977661},{"id":"https://openalex.org/keywords/mechanism-of-action","display_name":"mechanism of action","score":0.8880000114440918},{"id":"https://openalex.org/keywords/carbamazepine","display_name":"carbamazepine","score":0.8199999928474426},{"id":"https://openalex.org/keywords/phenytoin","display_name":"phenytoin","score":1.0},{"id":"https://openalex.org/keywords/primidone","display_name":"primidone","score":0.8460000157356262},{"id":"https://openalex.org/keywords/phenobarbital","display_name":"phenobarbital","score":1.0},{"id":"https://openalex.org/keywords/clonazepam","display_name":"clonazepam","score":0.9990000128746033},{"id":"https://openalex.org/keywords/valproic-acid","display_name":"valproic acid","score":0.9990000128746033},{"id":"https://openalex.org/keywords/ethosuximide","display_name":"ethosuximide","score":0.9990000128746033},{"id":"https://openalex.org/keywords/membrane-excitability","display_name":"membrane excitability","score":0.8029999732971191},{"id":"https://openalex.org/keywords/synaptic-transmission","display_name":"synaptic transmission","score":0.9929999709129333},{"id":"https://openalex.org/keywords/generalized-tonic-clonic-seizures","display_name":"generalized tonic-clonic seizures","score":0.9210000038146973},{"id":"https://openalex.org/keywords/pentylenetetrazole-induced-seizures","display_name":"pentylenetetrazole-induced seizures","score":0.8949999809265137},{"id":"https://openalex.org/keywords/maximal-electroshock-seizures","display_name":"maximal electroshock seizures","score":0.9290000200271606},{"id":"https://openalex.org/keywords/benzodiazepines","display_name":"benzodiazepines","score":0.8519999980926514}],"concepts":[{"id":"https://openalex.org/C2779619453","wikidata":"https://www.wikidata.org/wiki/Q421567","display_name":"Ethosuximide","level":4,"score":0.9019458293914795},{"id":"https://openalex.org/C2779253243","wikidata":"https://www.wikidata.org/wiki/Q410412","display_name":"Carbamazepine","level":3,"score":0.8478065133094788},{"id":"https://openalex.org/C2775858608","wikidata":"https://www.wikidata.org/wiki/Q576618","display_name":"Anticonvulsant","level":3,"score":0.7623720169067383},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.7351914644241333},{"id":"https://openalex.org/C2777172819","wikidata":"https://www.wikidata.org/wiki/Q240642","display_name":"Valproic Acid","level":3,"score":0.691392183303833},{"id":"https://openalex.org/C2777992146","wikidata":"https://www.wikidata.org/wiki/Q420383","display_name":"Primidone","level":4,"score":0.6724132299423218},{"id":"https://openalex.org/C2776819090","wikidata":"https://www.wikidata.org/wiki/Q412391","display_name":"Pentylenetetrazol","level":4,"score":0.6610257625579834},{"id":"https://openalex.org/C2778337148","wikidata":"https://www.wikidata.org/wiki/Q410400","display_name":"Phenytoin","level":3,"score":0.6495488882064819},{"id":"https://openalex.org/C2778793413","wikidata":"https://www.wikidata.org/wiki/Q407241","display_name":"Phenobarbital","level":2,"score":0.6232022047042847},{"id":"https://openalex.org/C2779426884","wikidata":"https://www.wikidata.org/wiki/Q407988","display_name":"Clonazepam","level":2,"score":0.5389675498008728},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5079372525215149},{"id":"https://openalex.org/C197341189","wikidata":"https://www.wikidata.org/wiki/Q863533","display_name":"Postsynaptic potential","level":3,"score":0.4198686182498932},{"id":"https://openalex.org/C2779177108","wikidata":"https://www.wikidata.org/wiki/Q18356742","display_name":"GABAergic","level":3,"score":0.4123665392398834},{"id":"https://openalex.org/C2776120743","wikidata":"https://www.wikidata.org/wiki/Q3271540","display_name":"Mechanism of action","level":3,"score":0.4109684228897095},{"id":"https://openalex.org/C2778186239","wikidata":"https://www.wikidata.org/wiki/Q41571","display_name":"Epilepsy","level":2,"score":0.35716956853866577},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.22677430510520935},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.16282740235328674},{"id":"https://openalex.org/C17077164","wikidata":"https://www.wikidata.org/wiki/Q1185869","display_name":"Inhibitory postsynaptic potential","level":2,"score":0.14100930094718933},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.07579082250595093},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.04660141468048096},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.0},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000200","descriptor_name":"Action Potentials","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000927","descriptor_name":"Anticonvulsants","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D001463","descriptor_name":"Barbiturates","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D001569","descriptor_name":"Benzodiazepines","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D001696","descriptor_name":"Biomechanical Phenomena","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002220","descriptor_name":"Carbamazepine","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D005680","descriptor_name":"gamma-Aminobutyric Acid","qualifier_ui":"Q000502","qualifier_name":"physiology","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009435","descriptor_name":"Synaptic Transmission","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D010672","descriptor_name":"Phenytoin","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D011324","descriptor_name":"Primidone","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D013388","descriptor_name":"Succinimides","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D013569","descriptor_name":"Synapses","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D013569","descriptor_name":"Synapses","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D013569","descriptor_name":"Synapses","qualifier_ui":"Q000502","qualifier_name":"physiology","is_major_topic":false},{"descriptor_ui":"D014635","descriptor_name":"Valproic Acid","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D018377","descriptor_name":"Neurotransmitter Agents","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false}],"locations_count":2,"locations":[{"id":"pmid:2871724","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/2871724","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Advances in neurology","raw_type":"Journal Article"},{"id":"mag:34455977","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/2871724","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.9763000011444092,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2398131647","https://openalex.org/W2414138044","https://openalex.org/W1981942278","https://openalex.org/W2604800740","https://openalex.org/W2148029165","https://openalex.org/W2092385405","https://openalex.org/W2059513822","https://openalex.org/W2112852016","https://openalex.org/W2033869401","https://openalex.org/W2126863817"],"abstract_inverted_index":{"A":[0],"variety":[1],"of":[2,23,59,78,85,112,171,177,198,205,224,226],"the":[3,21,76,95,175],"anticonvulsant":[4,51,80,96],"drugs,":[5],"including":[6],"carbamazepine,":[7,179],"phenytoin,":[8,178],"primidone,":[9],"phenobarbital,":[10,180],"clonazepam,":[11],"valproic":[12,144,181],"acid,":[13,182],"and":[14,39,88,115,123,143,149,183,191,207,216,234],"ethosuximide,":[15],"are":[16],"available":[17],"for":[18,47],"use":[19],"in":[20,31,37,42,50,69,189,195,214,219,232,237],"treatment":[22],"patients":[24],"with":[25],"seizure":[26],"disorders.":[27],"These":[28],"anticonvulsants":[29],"vary":[30],"their":[32,103],"efficacy":[33,204],"against":[34,40,128,185,210,228],"experimental":[35,220,238],"seizures":[36,41,188,194,213,218,231,236],"animals":[38,239],"humans.":[43],"The":[44,222],"mechanistic":[45],"basis":[46],"this":[48],"variability":[49],"drug":[52],"action":[53,60,77,113,176,225],"remains":[54],"uncertain,":[55],"but":[56,130],"numerous":[57],"mechanisms":[58],"have":[61,65,92,167],"been":[62],"proposed.":[63],"We":[64,91],"used":[66],"mouse":[67],"neurons":[68],"primary":[70],"dissociated":[71],"cell":[72],"culture":[73],"to":[74,102],"study":[75],"these":[79,164],"drugs":[81,97,209],"on":[82,105,116,157,163],"several":[83],"aspects":[84],"membrane":[86],"excitability":[87],"synaptic":[89,200],"transmission.":[90],"proposed":[93,168],"that":[94,169],"can":[98],"be":[99,241],"classified":[100],"according":[101],"actions":[104],"sustained":[106],"high":[107],"frequency":[108],"repetitive":[109],"firing":[110],"(SRF)":[111],"potentials":[114],"postsynaptic":[117,134,150],"gamma-aminobutyric":[118],"acid":[119,145],"(GABA)":[120],"responses.":[121,152],"Phenytoin":[122],"carbamazepine":[124],"were":[125],"both":[126,147],"effective":[127],"SRF":[129,148,158,172],"did":[131],"not":[132],"modify":[133],"GABA":[135,151],"responses":[136],"at":[137],"therapeutically":[138],"relevant":[139],"concentrations.":[140],"Phenobarbital,":[141],"benzodiazepines,":[142],"modified":[146],"Ethosuximide":[153],"had":[154],"no":[155],"effect":[156],"or":[159],"GABAergic":[160,199],"mechanisms.":[161],"Based":[162],"results,":[165],"we":[166],"blockade":[170],"may":[173,202,240],"underlie":[174,203],"benzodiazepines":[184,206],"generalized":[186,211,229],"tonic-clonic":[187],"humans":[190,215,233],"maximal":[192],"electroshock":[193],"animals.":[196,221],"Enhancement":[197],"transmission":[201],"valproic-acid":[208],"absence":[212,230],"pentylenetetrazol-induced":[217,235],"mechanism":[223],"ethosuximide":[227],"by":[242],"a":[243],"third,":[244],"as":[245],"yet":[246],"unknown,":[247],"mechanism.":[248]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W34455977","counts_by_year":[{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":3},{"year":2023,"cited_by_count":3},{"year":2022,"cited_by_count":3},{"year":2021,"cited_by_count":3},{"year":2020,"cited_by_count":5},{"year":2019,"cited_by_count":3},{"year":2018,"cited_by_count":5},{"year":2017,"cited_by_count":5},{"year":2016,"cited_by_count":5},{"year":2015,"cited_by_count":5},{"year":2014,"cited_by_count":6},{"year":2013,"cited_by_count":6},{"year":2012,"cited_by_count":4}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2016-06-24T00:00:00"}
